Evidence map›Paper›PMID 38494462›Full record

ReviewInternational journal of stroke : official journal of the International Stroke Society2024

Reducing the global burden of cerebral venous thrombosis: An international research agenda.

Jonathan M Coutinho, Anita van de Munckhof, Diana Aguiar de Sousa, Sven Poli, Sanjith Aaron, Antonio Arauz, Adriana B Conforto, Katarzyna Krzywicka, Sini Hiltunen, Erik Lindgren and 32 more

Abstract readReview
In one paragraph

Review in International journal of stroke : official journal of the International Stroke Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Stroke Care in Conflict and War Zones -Peace Saves Lives!Current neurology and neuroscience reports · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Thrombus Composition in Cerebral Venous Thrombosis.Stroke research and treatment · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Jonathan M CoutinhoDepartment of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Anita van de MunckhofDepartment of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-6028-3426
Diana Aguiar de SousaStroke Center, Centro Hospitalar Universitário Lisboa Central, Institute of Anatomy, Faculdade de Medicina, Universidade de Lisboa, and L Lopes Lab, Instituto de Medicina Molecular JLA, Lisbon, Portugal.ORCID 0000-0002-6702-7924
Sven PoliDepartment of Neurology & Stroke, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-0286-8781
Sanjith AaronChristian Medical College Hospital, Vellore, India.ORCID 0000-0002-5151-1500
Antonio ArauzInstituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico.
Adriana B ConfortoLIM-44, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Katarzyna KrzywickaDepartment of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Sini HiltunenHelsinki University Hospital and University of Helsinki, Helsinki, Finland.
Erik LindgrenDepartment of Neurology, Sahlgrenska University Hospital and Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Mayte Sánchez van KammenDepartment of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Liqi ShuBrown University, Providence, RI, USA.
Tamam BakchoulCentre for Clinical Transfusion Medicine, Medical Faculty of Tübingen, University of Tübingen, Tübingen, Germany.
Rosalie BelderNetherlands Thrombosis Foundation, Voorschoten, The Netherlands.
René van den BergDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Elisheva BoumansPatients' Representative, The Netherlands.
Suzanne CannegieterDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Vanessa Cano-NigendaInstituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico.ORCID 0000-0002-8544-9717
Thalia S FieldVancouver Stroke Program, Division of Neurology, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-1176-0633
Isabel FragataStroke Center, Centro Hospitalar Universitário Lisboa Central, Institute of Anatomy, Faculdade de Medicina, Universidade de Lisboa, and L Lopes Lab, Instituto de Medicina Molecular JLA, Lisbon, Portugal.ORCID 0000-0002-7037-7458
Mirjam R HeldnerInselspital Bern, University Hospital and University of Bern, Bern, Switzerland.
María Hernández-PérezHospital Germans Trias i Pujol, Badalona, Spain.ORCID 0000-0001-8279-7954
Frederikus A KlokDepartment of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
Ronen R LekerHadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID 0000-0003-4794-0334
Lia Lucas-NetoNorth Lisbon University Hospital Center and Lisbon Medical School, Lisbon, Portugal.
Jeremy MoladTel Aviv Medical Center, Tel Aviv, Israel.ORCID 0000-0001-6868-4849
Thanh N NguyenBoston Medical Center, Boston, MA, United States.
Dirk-Jan SaaltinkDutch Brain Foundation, The Hague, The Netherlands.
Gustavo SaposnikStroke Outcomes & Decision Neuroscience Research Unit, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-5950-9886
Pankaj SharmaRoyal Holloway University of London, London, United Kingdom.
Jan StamDepartment of Neurology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Vincent ThijsFlorey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.ORCID 0000-0002-6614-8417
Michiel van der VaartDutch Heart Foundation, The Hague, The Netherlands.ORCID 0000-0003-0828-7088
David J WerringUCL Queen Square Institute of Neurology, London, United Kingdom.ORCID 0000-0003-2074-1861
Diana Wong RamosPortugal AVC-União de Sobreviventes, Familiares e Amigos, Portugal.
Shadi YaghiBrown University, Providence, RI, USA.
Nilüfer YeşilotIstanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.ORCID 0000-0002-9655-9487
Turgut TatlisumakDepartment of Neurology, Sahlgrenska University Hospital and Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Jukka PutaalaHelsinki University Hospital and University of Helsinki, Helsinki, Finland.
Katarina JoodDepartment of Neurology, Sahlgrenska University Hospital and Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Marcel ArnoldInselspital Bern, University Hospital and University of Bern, Bern, Switzerland.
José M FerroHospital da Luz, University of Lisbon, Lisbon, Portugal.ORCID 0000-0002-2343-9097

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to the rarity of cerebral venous thrombosis (CVT), performing high-quality scientific research in this field is challenging. Providing answers to unresolved research questions will improve prevention, diagnosis, and treatment, and ultimately translate to a better outcome of patients with CVT. We present an international research agenda, in which the most important research questions in the field of CVT are prioritized.

aimsThis research agenda has three distinct goals: (1) to provide inspiration and focus to research on CVT for the coming years, (2) to reinforce international collaboration, and (3) to facilitate the acquisition of research funding. SUMMARY OF REVIEW: This international research agenda is the result of a research summit organized by the International Cerebral Venous Thrombosis Consortium in Amsterdam, the Netherlands, in June 2023. The summit brought together 45 participants from 15 countries including clinical researchers from various disciplines, patients who previously suffered from CVT, and delegates from industry and non-profit funding organizations. The research agenda is categorized into six pre-specified themes: (1) epidemiology and clinical features, (2) life after CVT, (3) neuroimaging and diagnosis, (4) pathophysiology, (5) medical treatment, and (6) endovascular treatment. For each theme, we present two to four research questions, followed by a brief substantiation per question. The research questions were prioritized by the participants of the summit through consensus discussion.

conclusionsThis international research agenda provides an overview of the most burning research questions on CVT. Answering these questions will advance our understanding and management of CVT, which will ultimately lead to improved outcomes for CVT patients worldwide.

Indexed as

Intracranial ThrombosisVenous ThrombosisBiomedical ResearchHumansInternational CooperationCVTepidemiologyinternationalpathophysiologysummitthrombosistreatment

Identifiers

PMID38494462
PMCPMC11292977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.